EcoDrugPlus

Tek Receptor Tyrosine Kinase

Ensembl ID : ENSTBEG00000004627
Gene Symbol: TEK
1 Cross references
164 Possible Orthologues:

Ttk Protein Kinase

Ensembl ID : ENSTBEG00000001859
Gene Symbol: TTK
1 Cross references
203 Possible Orthologues:

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSTBEG00000011691
Gene Symbol: UGCG
1 Cross references
211 Possible Orthologues:

Yes Proto-Oncogene 1, Src Family Tyrosine Kinase

Ensembl ID : ENSTBEG00000000814
Gene Symbol: YES1
1 Cross references
267 Possible Orthologues:

Acetylcholinesterase (Cartwright Blood Group)

Ensembl ID : ENSTBEG00000006472
Gene Symbol: ACHE
1 Cross references
233 Possible Orthologues:

Activin A Receptor Type 2b

Ensembl ID : ENSTBEG00000010485
Gene Symbol: ACVR2B
1 Cross references
257 Possible Orthologues:

Adenosine A2b Receptor

Ensembl ID : ENSTBEG00000014109
Gene Symbol: ADORA2B
1 Cross references
200 Possible Orthologues:

Adenosine Deaminase

Ensembl ID : ENSTBEG00000014824
Gene Symbol: ADA
1 Cross references
216 Possible Orthologues:

Adrenoceptor Alpha 1a

Ensembl ID : ENSTBEG00000006921
Gene Symbol: ADRA1A
1 Cross references
201 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSTBEG00000004001
Gene Symbol: ADRA1B
1 Cross references
263 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSTBEG00000004064
Gene Symbol: ADRB2
1 Cross references
263 Possible Orthologues:

Advanced Glycosylation End-Product Specific Receptor

Ensembl ID : ENSTBEG00000016337
Gene Symbol: AGER
1 Cross references
169 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).